
The current protocol for HPV 16/18 vaccine, 3 doses over 6 months, can be expensive and inconvenient. Now, a new study suggests that fewer than 3 doses may be just as effective as the standard 3-dose regimen when it comes to preventing cervical cancer with one of the approved vaccines. Find out how this discovery came about and how it potentially could be used to increase vaccination rates.


